BNP Paribas Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $130M | Sell |
1,032,296
-222,810
| -18% | -$28M | 0.32% | 62 |
|
2025
Q1 | $139M | Buy |
1,255,106
+310,368
| +33% | +$34.3M | 0.37% | 54 |
|
2024
Q4 | $129M | Buy |
944,738
+124,770
| +15% | +$17M | 0.32% | 68 |
|
2024
Q3 | $94.5M | Buy |
819,968
+37,098
| +5% | +$4.27M | 0.23% | 99 |
|
2024
Q2 | $108M | Sell |
782,870
-7,323
| -0.9% | -$1.01M | 0.28% | 81 |
|
2024
Q1 | $109M | Buy |
790,193
+69,600
| +10% | +$9.6M | 0.29% | 77 |
|
2023
Q4 | $94.9M | Buy |
720,593
+42,263
| +6% | +$5.57M | 0.26% | 94 |
|
2023
Q3 | $76.3M | Buy |
678,330
+21,308
| +3% | +$2.4M | 0.23% | 107 |
|
2023
Q2 | $62M | Buy |
657,022
+44,368
| +7% | +$4.18M | 0.19% | 130 |
|
2023
Q1 | $62M | Buy |
612,654
+61,297
| +11% | +$6.2M | 0.21% | 114 |
|
2022
Q4 | $65.9M | Buy |
551,357
+17,851
| +3% | +$2.13M | 0.24% | 109 |
|
2022
Q3 | $56.7M | Buy |
533,506
+85,689
| +19% | +$9.1M | 0.22% | 106 |
|
2022
Q2 | $43.7M | Buy |
447,817
+88,840
| +25% | +$8.66M | 0.17% | 143 |
|
2022
Q1 | $33.7M | Sell |
358,977
-13,615
| -4% | -$1.28M | 0.12% | 210 |
|
2021
Q4 | $31.7M | Sell |
372,592
-19,158
| -5% | -$1.63M | 0.11% | 235 |
|
2021
Q3 | $37.6M | Sell |
391,750
-1,192
| -0.3% | -$114K | 0.14% | 184 |
|
2021
Q2 | $38.2M | Buy |
392,942
+69,482
| +21% | +$6.76M | 0.14% | 190 |
|
2021
Q1 | $31.5M | Buy |
323,460
+65,431
| +25% | +$6.36M | 0.13% | 186 |
|
2020
Q4 | $24.7M | Sell |
258,029
-5,867
| -2% | -$562K | 0.11% | 215 |
|
2020
Q3 | $25.4M | Buy |
263,896
+42,543
| +19% | +$4.09M | 0.14% | 176 |
|
2020
Q2 | $27M | Sell |
221,353
-14,531
| -6% | -$1.77M | 0.18% | 151 |
|
2020
Q1 | $20.4M | Buy |
235,884
+32,994
| +16% | +$2.86M | 0.17% | 160 |
|
2019
Q4 | $21.8M | Sell |
202,890
-95,184
| -32% | -$10.2M | 0.15% | 189 |
|
2019
Q3 | $26.9M | Sell |
298,074
-106,738
| -26% | -$9.62M | 0.21% | 136 |
|
2019
Q2 | $34.2M | Buy |
404,812
+37,933
| +10% | +$3.2M | 0.28% | 90 |
|
2019
Q1 | $32.3M | Buy |
366,879
+186,150
| +103% | +$16.4M | 0.27% | 89 |
|
2018
Q4 | $12.4M | Sell |
180,729
-11,723
| -6% | -$802K | 0.11% | 248 |
|
2018
Q3 | $23.7M | Sell |
192,452
-53,695
| -22% | -$6.6M | 0.18% | 155 |
|
2018
Q2 | $24.2M | Buy |
246,147
+136,401
| +124% | +$13.4M | 0.2% | 133 |
|
2018
Q1 | $9.1M | Sell |
109,746
-141,453
| -56% | -$11.7M | 0.08% | 343 |
|
2017
Q4 | $19.5M | Sell |
251,199
-271,602
| -52% | -$21.1M | 0.17% | 161 |
|
2017
Q3 | $32M | Buy |
522,801
+133,175
| +34% | +$8.16M | 0.27% | 80 |
|
2017
Q2 | $17.9M | Buy |
389,626
+180,437
| +86% | +$8.3M | 0.16% | 165 |
|
2017
Q1 | $9.06M | Buy |
209,189
+23,782
| +13% | +$1.03M | 0.08% | 336 |
|
2016
Q4 | $7.18M | Buy |
185,407
+14,615
| +9% | +$566K | 0.07% | 385 |
|
2016
Q3 | $8.65M | Sell |
170,792
-12,471
| -7% | -$632K | 0.07% | 365 |
|
2016
Q2 | $8.33M | Buy |
183,263
+124,022
| +209% | +$5.64M | 0.07% | 361 |
|
2016
Q1 | $2.34M | Buy |
+59,241
| New | +$2.34M | 0.02% | 645 |
|
2015
Q2 | – | Sell |
-17,231
| Closed | -$684K | – | 1060 |
|
2015
Q1 | $684K | Sell |
17,231
-1,632
| -9% | -$64.8K | 0.01% | 896 |
|
2014
Q4 | $421K | Buy |
+18,863
| New | +$421K | ﹤0.01% | 866 |
|
2013
Q4 | – | Sell |
-184,125
| Closed | -$2.08M | – | 840 |
|
2013
Q3 | $2.08M | Sell |
184,125
-56,452
| -23% | -$639K | 0.02% | 590 |
|
2013
Q2 | $3.22M | Buy |
+240,577
| New | +$3.22M | 0.02% | 525 |
|